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Abstract
Background: Outbreaks of infections caused by rapidly growing mycobacteria have been reported worldwide
generally associated with medical procedures. Mycobacterium abscessus subsp. massiliense CRM0019 was obtained
during an epidemic of postsurgical infections and was characterized by increased persistence in vivo. To better
understand the successful survival strategies of this microorganism, we evaluated its infectivity and proliferation in
macrophages (RAW and BMDM) and alveolar epithelial cells (A549). For that, we assessed the following parameters,
for both M. abscessus CRM0019 as well as the reference strain M. abscessus ATCC 19977: internalization, intracellular
survival for up 3 days, competence to subvert lysosome fusion and the intracellular survival after cell reinfection.
Results: CRM0019 and ATCC 19977 strains showed the same internalization rate (approximately 30% after 6 h
infection), in both A549 and RAW cells. However, colony forming units data showed that CRM0019 survived better in
A549 cells than the ATCC 19977 strain. Phagosomal characteristics of CRM0019 showed the bacteria inside tight
phagosomes in A549 cells, contrasting to the loosely phagosomal membrane in macrophages. This observation holds
for the ATCC 19977 strain in both cell types. The competence to subvert lysosome fusion was assessed by acidification
and acquisition of lysosomal protein. For M. abscessus strains the phagosomes were acidified in all cell lines;
nevertheless, the acquisition of lysosomal protein was reduced by CRM0019 compared to the ATCC 19977 strain, in
A549 cells. Conversely, in macrophages, both M. abscessus strains were located in mature phagosomes, however
without bacterial death. Once recovered from macrophages M. abscessus could establish a new intracellular infection.
Nevertheless, only CRM0019 showed a higher growth rate in A549, increasing nearly 10-fold after 48 and 72 h.
Conclusion: M. abscessus CRM0019 creates a protective and replicative niche in alveolar epithelial cells mainly by
avoiding phagosome maturation. Once recovered from infected macrophages, CRM0019 remains infective and displays
greater intracellular growth in A549 cells compared to the ATCC 19977 strain. This evasion strategy in alveolar epithelial
cells may contribute to the long survival of the CRM0019 strain in the host and thus to the inefficacy of in vivo treatment.
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Background
Mycobacterium abscessus is a nontuberculous mycobac-
terium (NTM) widely distributed in the environment.
This bacterium is responsible for lung diseases [1, 2] and
healthcare-associated extrapulmonary infections [3–5].
M. abscessus is indeed the major pulmonary pathogen
within the rapid-growing mycobacteria (RGM) group
[2], and it has been the most frequent NTM found in
the lungs of cystic fibrosis (CF) patients [6–8].
As for other NTM, M. abscessus is present in environ-
mental reservoirs (e.g. water and soil) and has been re-
cently isolated from drinking water [9–11]. The
acquisition of this bacterium is therefore most likely to
occur from the environment, rather than via person-to-
person transmission [12]. Despite sharing genes typically
found in environmental organisms [13], M. abscessus
also harbors genes characteristic of pathogenic bacteria
[14, 15]. Likewise, it is an intracellular pathogen of mac-
rophages and free-living amoebas [16, 17].
M. abscessus has been classified into three subspecies
that are officially accepted: M. abscessus subsp. absces-
sus, M. abscessus subsp. massiliense and M. abscessus
subsp. bolletii [18]. These subspecies cause similar
diseases but can be differentiated by PCR-restriction
enzyme analysis (PRA) of the hsp65 gene, rpoB gene
sequencing and polymorphisms in the erm gene [19]. M.
abscessus pathogenicity is closely related to its colony
morphology on an agar plate: organisms without glyco-
peptidolipids (GPLs) on their surface show a rough (R)
colony morphology, while those with GPLs display a
smooth (S) morphology [16, 20–22]. The S variant is
motile, biofilm-forming, and less virulent [16, 21, 23]. By
contrast, the R variant is non-motile, but more virulent
than the S variant [16]. In the lung, M. abscessus infec-
tion appears to be associated with the R variant, which
has a highly persistent behavior [16, 24, 25]. Even so,
both morphotypes R and S can be isolated from clinical
samples [23, 26, 27], and an interchange between these
forms may possibly occur [16, 21]. The clinical isolate
M. abscessus subsp. massiliense CRM0019 was obtained
during an epidemic of postsurgical infections related to
laparoscopic, arthroscopic and plastic surgeries in 2006,
in Rio de Janeiro city, Brazil [28–30] and showed a
smooth morphotype upon isolation (“personal commu-
nication” by Dr. Rafael Duarte). This isolate belongs to a
strain that affected more than 2000 patients between
2004 and 2008 [29, 30], and has substantial tolerance to
high concentrations of glutaraldehyde [31].
The numerous cases of M. abscessus infection related
to a single clone reported in Brazil raised questions
about the transmission of this bacterium and its survival
in the host. From these questions, studies have mostly
been conducted regarding bacterial survival. CRM0019
has increased persistence in vivo [32], which can be
attributed to the capacity of M. abscessus to manipulate
host immune responses in macrophages, epithelial cells,
endothelial cells and neutrophils [33–38]. Nonetheless,
little is known about the interaction of the CRM0019
isolate with lysosomes or its capacity for reinfection.
This is an essential question to address in order to
understand the successful intracellular survival of patho-
genic mycobacteria, classically represented by M. tuber-
culosis, which arrests progression of phagosome
maturation [39, 40]. Macrophages often fail to kill
pathogenic mycobacteria, resulting in survival and pro-
liferation of the bacilli [41–43] as observed for other
NTM [44, 45] including the CRM0019 isolate [32].
Besides macrophages, the respiratory epithelium plays
an important role in defending against respiratory patho-
gens [46]. There is evidence that epithelial cells can act
as a replicative niche for Mycobacterium [47–52]. Even
so, their contribution to the pathogenicity in humans is
not as yet clear. A recent study using a human ex vivo
lung tissue culture model reinforced the evidence for
mycobacteria infection in alveolar epithelial cells (AEC)
[53]. A549 is a human type II carcinoma cell line estab-
lished as a model of type II AEC [54, 55]. As such, this
cell line has been extensively used to study lung infec-
tions with a range of pathogens [56–58] including myco-
bacteria [49, 50, 59, 60]. Besides being shielded from
phagocytic cells, mycobacteria inside AEC could acquire
a more infective phenotype. Indeed, it has been shown
that passage of mycobacteria through alveolar epithelial
cells promotes the conversion of non-virulent M. smeg-
matis to a virulent phenotype before they infect macro-
phages [61]. Likewise, a recent study also showed that
M. abscessus obtained from amoeba are more infective
than those growing extracellularly [62].
Understanding the survival mechanisms engaged by
M. abscessus CRM0019 in cells other than macrophages
may shed light on important aspects of its intracellular
behavior that could play a role in its in vivo persistence
and virulence. We investigated herein the intracellular
survival of M. abscessus CRM0019 in comparison to ref-
erence strain M. abscessus ATCC 19977 in both A549
epithelial cells and macrophages, by addressing the inter-
action with lysosomes and reinfection capability.
Methods
Cell cultures
The cell lines A549 - type II alveolar epithelial cell line
(DSMZ GmbH, Braunschweig, Germany) and RAW
264.7 - mouse leukemic monocyte macrophage cell line
(ATCC, Manassas VA, USA) were maintained respect-
ively in DMEM and RPMI medium (Sigma Chemical
Co., St Louis, MO.), both supplemented with 10% FBS
(Life Technologies, Grand Island, NY, USA), 100 μg/ml
streptomycin and 100 U/ml penicillin (Sigma). Cells
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were grown in T75 flasks in 5% CO2, at 37 °C. Cultures
were trypsinized upon reaching approximately 75% con-
fluence, and concentrated by centrifugation at 360 ×g at
25 °C for 10 min. Cells were counted in a Neubauer
chamber and viability assessed by trypan blue exclusion.
Bone marrow-derived macrophages (BMDM) were ob-
tained and cultivated as previously described [63] and
used after 6-7 days of differentiation.
Bacterial cultures
M. abscessus subsp. massiliense CRM0019 was isolated
from a postsurgical wound during the 2006-2007
epidemic in Rio de Janeiro, Brazil [28]. M. abscessus
subsp. abscessus smooth variant was isolated from the
sputum of CF patients [27], and kindly provided by Prof.
Dr. John Perry, Newcastle University. The reference
strain M. abscessus subsp. abscessus ATCC 19977 was
used in parallel. Both bacteria, ATCC 19977 and
CRM0019, were transformed with the Escherichia coli-
mycobacterium expression vector pMV262 containing
the green fluorescent protein (GFP) gene (pMV262-gfp).
In some experiments, M. smegmatis mc2155, wild type
or transformed with the same plasmid, was used. All
mycobacterial strains were grown in Middlebrook 7H9
liquid medium (Becton Dickinson, Franklin Lakes, NJ),
supplemented with oleic acid, albumin, dextrose and
catalase (OADC – Becton Dickinson), 0.5% glycerol and
0.05% Tween 80 at 37 °C, for 72 h. Transformed bacteria
were grown in medium containing kanamycin (50 μg/ml)
and sub-cultured in fresh medium for 24 h before the
experiments.
Mycobacteria-cells infection
A549 cells and macrophages (5 × 104 per well) previously
grown in 24-well plates in medium without antibiotics
were infected simultaneously with single-cell bacterial
suspensions. Accordingly, bacterial cells in exponential
growth phase were pelleted, washed in PBS and sus-
pended in DMEM. Clumps of bacteria were removed by
passing through a syringe needle (25 gauge), followed by
an ultrasonic water bath for 15 min and low-speed cen-
trifugation (120 ×g) for 2 min. The optical densities of
bacterial suspensions were adjusted to a multiplicity of
infection (MOI) of 10 or 100, according to the experi-
ment. MOI of 10 was used for macrophages and MOI of
100 for A549 cells. The experiments with M. smegmatis
followed the same protocols as used for M. abscessus.
After 6 h uptake, the cells were washed with PBS to
remove extracellular bacteria. Thereafter cells were incu-
bated with DMEM containing 30 μg/ml amikacin
(Sigma) to avoid extracellular bacteria growth [16]. In-
fected cultures were further incubated for 6, 24, 48 and
72 h at 37 °C, in 5% CO2.
Colony-forming unit assay
Infected macrophages and A549 cells were washed
with PBS and lysed with sterilized water. Quantitative
cultures for mycobacteria were performed using 10-
fold serial dilutions in PBS/0.05% Tween 80 inoculated
on LB agar plates. Subsequently, 20 μl were plated in
triplicate with serial dilutions. The plates were incu-
bated at 37 °C and the colonies counted after 3 or
4 days. Results were expressed in terms of colony-
forming units (CFU) per milliliter.
To verify the infectivity competence of mycobacteria
in reinfection assays, mycobacteria were obtained from
BMDM previously infected for 24 h. Macrophages
were lysed and bacterial suspensions frozen at −20 °C
with 10% glycerol. Before use in experiments, bacteria
were grown in 7H9 liquid fresh medium for 72 h and
prepared for cell infection as described above.
Fluorescence microscopy
For lysosome-staining assays, A549 cells and macro-
phages were fixed with 3% paraformaldehyde (PFA) in
PBS for 15 min at room temperature and quenched for
15 min with 50 mM glycine in PBS. Preceding immu-
nostaining, cells were permeabilized with 0.1% saponin
solution and 1% bovine serum albumin (BSA - Sigma)
in PBS, for 15 min at room temperature. For A549
cells, mouse α-human and for RAW cells rabbit α-
mouse LAMP-1 and α-cathepsin D antibodies (super-
natants from DSHB, Iowa University, USA) were used
at 1:10 dilution for 1 h. The corresponding fluorescent
secondary antibodies, α-mouse-IgG for A549 cells and
α-rabbit-IgG for RAW cells (AlexaFluor), were used at
a dilution of 1:250 for 1 h at room temperature. Alter-
natively, live adherent cells were infected as described
before and incubated with medium containing 200 nM
LysoTracker Red DND-99 (Molecular Probes, Thermo
Scientific) for 1 h at 37 °C, to evaluate phagosomal
acidification. Afterwards, cells were washed with HBSS
(Sigma) and coverslips were fixed with 4% PFA for
15 min.
Nuclear staining was performed using 5 nM 4,6′-dia-
midino-2-phenylindole (DAPI, Invitrogen, Thermo
Scientific). After staining, the coverslips were mounted
on slides using aqueous mounting medium (Dako
Cytomation, Denmark). Samples were analyzed by epi-
fluorescence microscopy using a Zeiss Axiovert Fluor-
escence microscope (Zeiss, Germany) or Leica SP5 II
TS confocal microscope (Leica Microsystems,
Germany) microscope. Microscopic images of fixed
samples were acquired at 1024 × 1024 resolution, using
a 100× (HCX PL APO 100×/1.44 CORR CS) oil
immersion objective and z-stacks with steps ranging
from 0.3 to 0.5 μm.
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Live cell images
Live imaging was performed by serial acquisition of im-
ages from live A549 cells pre-loaded with LysoTracker
Red (200 nM) and infected with M. abscessus ATCC
19977 or M. smegmatis mc2155 for up to 36 h. The cells
were placed in microincubators coupled to the confocal
system. Images were taken every 15 min. Lasers were ad-
justed to no more than 5% of potency at resonant scan-
ning mode (4000 Hz) to minimize phototoxicity.
Multichamber Hi-Q4 dishes (Ibidi GmbH) were
employed for experiments in which two different cell
cultures, infected with different mycobacteria, were im-
aged in the same live imaging session. Different micro-
scopic fields could be imaged for each condition using
the multiposition tool of the confocal system.
Confocal images were analyzed with Imaris v.7.4.2
software (Bitplane AG, Andor Technology). The soft-
ware allowed the construction of isosurfaces based on
GFP signaling of the bacteria [64] that retrieves different
morphological parameters such as bacterial volume, area
and fluorescence intensity. These isosurfaces represent
the region where the GFP signal of the bacteria is
located in multidimensional images; they could be used
to recover the fluorescence intensity of the Lysotracker
Red DND-99 probe that represents the acquisition of
this lysosomal probe in the bacteria-containing phago-
some. Thus, the relative fluorescence intensity of Lyso-
Tracker Red detected by GFP-constructed bacterial
isosurfaces is an inference of phagosomal acidification
that could be measured dynamically in live cell imaging.
Flow cytometry
A549 and RAW cells grown in 24-well plates, non-
infected or infected with wild-type or GFP-expressing
strains (CRM0019 or ATCC 19977) as described before
were trypsinized after 6, 24, 48 and 72 h of infection
and collected with 1 ml of DMEM containing 10% FBS.
Cells were then centrifuged at 860 ×g for 10 min at
room temperature, washed with PBS, and fixed with 4%
PFA for 20 min at room temperature. After one add-
itional PBS washing, the samples were resuspended in
500 μl of PBS with 10% FBS at 4 °C and immediately
analyzed in a FACSCalibur flow cytometer (Becton
Dickinson, San Jose, CA).
Intracellular infection was evaluated with FlowJo soft-
ware (version 9.7.6, Tree Star, San Carlos, CA). For this,
cells infected with wild-type M. abscessus or not were
used as control groups. At each evaluated time, the posi-
tive fluorescent region was defined on the basis of con-
trol samples, which were GFP-negative, determining the
percentage of infected cells (GFP-positive cells). The
infection efficacy was determined as the fluorescence
intensity of GFP-positive cells minus negative control
values, and the mean fluorescence intensity (MFI) was
calculated, using geometric mean value. The progression
of infection by different strains over time was analyzed by
comparing the fluorescence ratio, which was calculated
for each time point as (GFP+ MFI)/(GFP+ MFI + GFP−
MFI).
Transmission electron microscopy
Macrophages or A549 cells were grown in 75 cm2 flasks
and infected with M. abscessus, clinical or reference
strain, as described before. The cultures were washed
with PBS and fixed with a solution containing 2.5% glu-
taraldehyde, 2% formaldehyde, 5 mM CaCl2 and 5% su-
crose in 0.1 M sodium cacodylate buffer, pH 7.2, for 1 h
at room temperature. Samples were post-fixed in 0.1 M
sodium cacodylate buffer, pH 7.2 containing 0.8% os-
mium tetroxide and 2% potassium ferricyanide for 1 h,
followed by dehydration with a graded series of acetone
(70, 90 and 100%) and propylene oxide for 10 min each
at room temperature. Afterwards, the cells were embed-
ded in epoxy resin. Ultrathin sections (50-60 nm) were
cut with a diamond knife, collected onto Butvar-coated
copper grids, post-stained with 2% uranyl acetate
(3 min) and lead citrate (1 min) and observed with a
transmission electron microscope (Jeol 1200EX) at an
accelerating voltage of 80 kV.
Methyl-thiazolyl tetrazolium (MTT) reduction assay
Cells were seeded in 96-well plates in triplicate at a density
of 1 × 105 cells per well 24 h before infection. Thereafter,
cells were infected for 6-72 h as described before and the
viability checked with MTT (Sigma), following the manu-
facturer’s instructions. The plates were read at 540 nm
using a plate reader (Multiskan MS, Labsystem).
Statistical analysis
All data were recorded as mean ± SD, from 2 or 3 inde-
pendent experiments, as indicated in the respective fig-
ure captions. Statistical analysis was performed using the
software package Prism6® (GraphPad Prism, San Diego,
CA, USA). Significance was determined by t-test or two-
way ANOVA, with Bonferroni posttest. Differences were
considered statistically significant at p < 0.05.
Results
Comparative internalization and survival of M. abscessus
strains
To evaluate M. abscessus infection and survival in epi-
thelial cells (A549) and macrophages (RAW and
BMDM), the clinical strain M. abscessus CRM0019 and
the reference strain M. abscessus ATCC 19977 were used
to infect cells for 6 to 72 h. Infected cells were fixed and
analyzed by flow cytometry. The percentage of infected
cells (GFP-positive cells) was determined for A549 and
RAW cells (Fig. 1a, b). The internalization rate of both
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strains was similar in both cell lines, with approximately
30% infection after 6 h. However, for RAW cells the pro-
portion of infected cells decreased after 72 h, to 15% in
the case of both strains. Such a reduction in the percent-
age of infected cells is most likely due to the proliferation
of uninfected cells in the same culture, as the infection it-
self did not induce cell death (see Additional file 1). For
primary macrophages (BMDM) a similar reduction in the
cell viability was observed, in both infected and uninfected
cultures (see Additional file 1 C). These results are not un-
expected, since primary cells are usually characterized as
having a short life span.
Intracellular bacterial survival was determined by CFU
counting of viable bacilli over a period of 72 h. Despite
the similar infection rate in A549 cells, CRM0019
showed higher survival and proliferative capability com-
pared to the ATCC 19977 strain, resulting in sustained
infection after 24 h (Fig. 2a). Similar behavior in
A549 cells was observed for another clinical strain of
M. abscessus, also with S morphotype, and recently
isolated from sputum of CF patients. The efficient
survival in A549 cells could also be observed in cul-
tures without amikacin, in which, as expected, more
colonies were obtained compared to the untreated culture
(see Additional file 2). For both, RAW and BMDM mac-
rophages, a similar intracellular survival of CRM0019 and
ATCC 19977 strains was seen Fig. 2 b, c).
The growth rate of the two bacterial strains was deter-
mined (see Additional file 3) by calculating the ratio be-
tween CFU obtained at 6 h (Ti) and the additional time
points (Tf), i.e., 24, 48 and 72 h. The clinical strain
showed approximately 20-fold increase in the number of
intracellular bacilli in A549 cells, while the reference
strain showed an increase of approximately 5-fold. In
macrophages, both strains showed the same growth rate
over time, which is in line with the CFU counts obtained
in Fig. 2 b, c. Despite being highly infective, M. abscessus
did not induce host cell death during the experimental
period (see Additional file 1).
Intracellular proliferation of M. abscessus was also
confirmed by flow cytometry (Fig. 3). The growth was
evaluated by comparing cells infected with GFP-
expressing bacteria either with uninfected cells or cells
infected with wild-type strains. The fluorescence ratio of
infected cells increased during the 72 h period of infec-
tion in A549 and RAW cells (Fig. 3 a). The increasing
GFP fluorescence observed over time, visualized as a dis-
placement of the GFP-positive population to the right in
the histograms, was consistent with the increasing num-
bers of intracellular bacteria (Fig. 3 b).
Phagosomal characteristics of M. abscessus strains in
epithelial cells and macrophages
Ultrastructural analyses and phagosome acidification
studies were carried out to characterize phagosomes
containing M. abscessus as well as host cell-lysosomal
system interaction. After 24 h of infection, M. abscessus
ATCC 19977 and M. abscessus CRM0019 were localized
inside vacuoles in A549 cells and macrophages (Fig. 4).
Representative TEM pictures show the characteristics of
each strain, either in A549 or RAW cells. A549 phago-
somes containing the clinical strain showed their mem-
brane closely apposed to the mycobacterial cell surface,
characteristic for R strains (Fig. 4 a). In RAW cells how-
ever, CRM0019 was also located in single phagosomes,
but the phagosomal membrane was separated from the
bacteria cell wall (Fig. 4 b). For the reference strain
ATCC 19977, phagosomes showed a “loose” apposed
membrane in both cell types (Fig. 4 c, d), characteristic
of S variant strains. Moreover, most of the phagosomes
here contained several bacteria.
Fig. 1 Internalization rate of Mycobacterium abscessus CRM0019 and
Mycobacterium abscessus ATCC 19977. a and b Percentage of infected
cells determined by flow cytometry, for both A549 (a) and RAW
(b) cells. No significant difference was observed between the strains
at each time point. Data represent mean +/− SD from 3
independents experiments
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Phagosome maturation was evaluated in infected A549
and RAW cells previously loaded with the lysosomal
marker LysoTracker Red. M. smegmatis mc2155 was
used in parallel as a control mycobacterium that allows
lysosome fusion [60, 65]. Live cell images were taken to
follow mycobacterium phagosome acidification in Lyso-
Tracker Red pre-loaded A549 cells (Fig. 5). M. smegma-
tis phagosomes were much more acidified than M.
abscessus phagosomes (Fig. 5 a, b). The sequence of im-
ages of M. abscessus phagosomes (Fig. 5 a) showed
bacteria-GFP surrounded by LysoTracker Red-positive
vesicles without a clear colocalization of phagosomes
and mycobacteria. Similar results were observed for
CRM0019 after 48 h infection in A549 cells, in which
bacteria showed slight colocalization with acidic vesicles
(see Additional file 4). With M. smegmatis there was evi-
dent colocalization of the mycobacteria (Fig. 5 b), and
LysoTracker Red was observed in some recorded phago-
somes, particularly in the first hours. Square regions of
the multidimensional images (in yellow) were selected to
measure LysoTracker Red intensity associated with the
bacteria (Fig. 5 c). The mean LysoTracker Red fluores-
cence intensity in regions where mycobacteria were lo-
cated was retrieved in arbitrary units and plotted in
relation to the acquisition time points (in hours). M.
abscessus ATCC 19977 phagosomes in A549 cells
showed lower LysoTracker Red fluorescence intensity
compared to the intensity produced by M. smegmatis in-
fection (Fig. 5 c). To closely follow phagosomal matur-
ation, A549 and RAW cells infected with the two M.
abscessus strains were simultaneously immunolabeled
with LAMP-1 and cathepsin D. Z-stack images of M.
abscessus-infected A549 and RAW cells showed the
colocalization of cathepsin D and LAMP-1 in the
CRM0019 phagosomes (Fig. 6 a, b) as well as in the
ATCC 19977 phagosomes (see Additional file 5). Almost
80% of the vacuoles containing M. abscessus ATCC
19977 were positive for both lysosomal markers, in ei-
ther A549 or RAW cells (Fig. 6 c). However, for the clin-
ical strain CRM0019 only 30% of the vacuoles were
positive for LAMP-1 and cathepsin D in A549 cells. A
different result was obtained with RAW cells, in which
the maturation of M. abscessus CRM0019 phagosomes
was similar to that observed for M. abscessus ATCC
19977, where there was almost 80% lysosomal protein
colocalization.
Reinfection of M. abscessus strains obtained from
macrophages
Because of the evidence that mycobacteria become more
infective after the first intracellular infection [61, 62], we
evaluated whether this holds for M. abscessus obtained
from macrophages. The aforementioned results showed
that M. abscessus were highly internalized by
Fig. 2 Intracellular survival of M. abscessus strains determined by
colony forming unit (CFU) counts. *p < 0.05; **p < 0.01; ***p < 0.001;
ns: not significant. Data represent mean +/− SD from 3
independents experiments
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macrophages and ended up in a mature lysosomal com-
partment without, however, evidence of intracellular
death (Figs. 2 and 6). Mycobacteria obtained from
BMDM previously infected for 24 h were used in re-
infection assays of A549 cells or new macrophages
(RAW and BMDM) (Fig. 7). The clinical strain showed
increased growth in A549 cells compared to ATCC
19977 (Fig. 7), in which higher CFU counts were ob-
tained after 48 and 72 h (Fig. 7 a). In RAW cells, this
was observed only after 72 h (Fig. 7 b); in the case of
BMDM, the number of colonies obtained with
CRM0019 was slightly higher compared to the reference
strain (Fig. 7 c). CRM0019 showed a higher growth rate
in A549 cells compared to the reference strain, mainly
after 48 and 72 h (see Additional file 6), with a nearly
10-fold increase. For both macrophage lines, the results
were similar to those observed in the first infection,
except for RAW cells infected with CRM0019 at 72 h
(see Additional file 3). Mycobacterial growth rate was
also determined for M. smegmatis, which showed no col-
onies after reinfection of all cell types (data not shown).
Discussion
M. abscessus subsp. massiliense CRM0019 survives in
macrophages and also subverts the immune response in
vivo, which may contribute to its increased persistence
[32]. Besides the ability to produce biofilms, limiting the
efficacy of treatment, intracellular growth may also con-
tribute to the successful survival of M. abscessus. In cul-
ture this bacteria exhibits two different colony
Fig. 3 Intracellular growth of M. abscessus strains by flow cytometry. Internalization of strain CRM0019 or ATCC 19977 in epithelial (A549) and
macrophage (RAW) cell lines was detected by flow cytometry after 6, 24, 48 and 72 h of infection. Intracellular growth was evaluated by calculating
fluorescence ratio (a) or with histograms of GFP fluorescence (b). Cells infected with wild-type bacteria and uninfected cells were used as negative
controls for GFP fluorescence. Statistical differences were calculated between 6 h, the first period of infection, and 24, and 72 h of infection. *p < 0.05
**p < 0.01 ***p < 0.001. Data represent mean +/− SD from 3 independents experiments
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Fig. 4 Ultrastructural characterization of M. abscessus phagosomes after 24 h of infection. a, b M. abscessus CRM019 in A549 (a) or RAW (b) cells;
(c, d) M. abscessus ATCC 19977 in A549 (c) or RAW (d) cells. Asterisks: host cell nuclei; arrow: intravacuolar bacteria; Bar: 0.5 μm
Fig. 5 Live cell imaging of infected A549 cells pre-loaded with LysoTracker Red. a M. abscessus ATCC 19977 and (b) M. smegmatis infection in
A549 cells for 36 h. Time of image acquisition is depicted as days:hours:minutes:seconds (d:hh:mm:ss) and image acquisition started after 2 h of
infection. c Mean fluorescence intensity of LysoTracker Red quantified from square regions in A and B. Total of 5 cells containing phagosomes
were analyzed per condition. Bar: 10 μm
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morphologies referred to as rough (R) and smooth (S)
morphotypes [21]. Despite the R morphotype being con-
sidered more virulent, S variants have been identified as
the dominant morphotype obtained from CF patients
[23]. Likewise, CRM0019 obtained during an epidemic
of postsurgical infections, displays an S morphotype
(“personal communication” by Dr. Rafael Duarte), and is
characterized by an aggressive and invasive behavior in
vivo [30].
For several decades, observations from in vivo histo-
logical samples of patients or animal models have shown
that macrophages are the predominant host cells for
mycobacteria. However, bacilli may be released from
macrophages and infect cells other than macrophages
thus establishing a stable or chronic infection. A recent
study using a human ex vivo lung model showed that
besides immune cells, Type II pneumocytes were also in-
fected with M. tuberculosis, M. avium and M. abscessus
[53]. For the isolate CRM0019 we know from previous
studies that this strain is highly virulent in vitro and
causes progressive lung infections in mice [32].
Based on these observations we investigated the intra-
cellular survival of the outbreak strain M. abscessus
CRM0019, focusing on its interaction with the primary
host defense system - lysosomal digestion, and its
reinfection capability.
Uptake of M. abscessus CRM0019 in A549 cells and
macrophages
There is considerable evidence towards the role of
epithelial cells as a replicative niche for Mycobacterium
survival [47–52, 54]. Herein, we showed similar internal-
ization rates for the clinical strain M. abscessus
CRM0019 as for the reference strain ATCC 19977 in
A549 cells. As expected, both strains were internalized
by macrophages, and the survival of M. abscessus was in
line with previously published data [16, 35, 66]. It has
been shown that S and R mycobacteria morphotypes
have distinct uptake efficacies in macrophages, most
likely due to the intrinsic clumping behavior of R strains
[35]. Despite our extensive procedures to obtain single
bacteria preparations, we also noticed a higher clumping
tendency of the clinical strain, which is atypical for S
Fig. 6 Colocalization of lysosomal proteins in M. abscessus CRM0019
phagosomes. a-f Z-stack images were obtained from A549 (a) and
RAW (b) cells infected with M. abscessus CRM0019 for 24 h. a and b:
Colocalization of mycobacteria-GFP, LAMP-1 and Cathepsin D, followed
by the respective separated channels of CRM0019-GFP, Cathepsin D,
LAMP-1 and transmitted light (DIC). c Quantification of M. abscessus
CRM0019 and M. abscessus ATCC 19977 phagosomes simultaneously
positive for LAMP-1 and cathepsin D in A549 and RAW cells. *P < 0.05.
200 phagosomes were counted per condition. Bar: 10 μm
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morphotypes. Even so, this did not interfere with the up-
take efficacy of CRM0019, either in A549 or RAW cells.
It is well known that the respiratory epithelium plays
an important role in host innate immune responses to
bacterial pathogens, through binding of the bacteria to
TLR (toll like receptors). M. abscessus variant lacking
GPL trigger immune responses in A549 cells through
TLR, contrasting to the S variant that is not recognized
by TLR2 [33]. Thus, we cannot exclude that CRM0019
can subvert innate immune responses triggered by TLR
binding. Such a strategy should therefore be further
investigated for M. abscessus CRM0019 strain.
Intracellular survival and intraphagosomal characteristics
of M. abscessus CRM0019 strain
In contrast to the similar internalization rate of
CRM0019 and ATCC 19977 in A549 cells, the intracel-
lular survival of CRM0019 was higher than the reference
strain as evidenced by CFU counts and flow cytometry
data. As amikacin was maintained during the entire ex-
periment, we believe that extracellular growth is quite
unlikely to contribute to the increased CFU number,
contrasting to what we observed in infected cultures
without amikacin (see Additional file 2). Such higher
survival of CRM0019 was unexpected and indeed more
correlated to R variant behavior [16]. This is contradict-
ory since the CRM0019 strain has S morphotype upon
isolation.
It is possible that the low CFU number obtained from
ATCC 19977 infection in A549 cells is due to a killing
activity against this strain. Since ATCC 19977 was iso-
lated in 1953, we cannot exclude a possible attenuation
after several passages in a laboratory setting. Another
reference strain, M. massiliense CIP 108297 – isolated in
2004 from the sputum of a patient with pneumonia -
also showed lower survival capability compared to the
clinical isolate CRM0019 [32]. Nevertheless we believe
that the difference between ATCC 19997 and CRM0019
survival might be related to the clinical significance of
CRM0019 rather than only to the attenuation of the ref-
erence strain. Our hypothesis is supported by the results
we obtained with another clinical strain (M. abscessus
subsp. abscessus), recently isolated from CF patients,
which showed higher survival in A549 cells, suggesting
therefore that wild strains share the potential to cause
disease.
Fig. 7 Intracellular survival of M. abscessus CRM0019 and M. abscessus
ATCC 19977 after cell-reinfection. a A549, b RAW and c BMDM were
infected with both strains, previously obtained from BMDM. In parallel,
intracellular growth was determined by CFU counts. Data represent
mean ± SD from 3 independent experiments. *p < 0.05; ***p < 0.001;
ns: not significant
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Epithelial cells may function as a protective niche for
M. abscessus survival, and there is existing evidence to
support this hypothesis. The first piece of evidence is
from recent transcriptional data showing upregulation of
genes in Type II epithelial cells related to the active pro-
liferation of M. tuberculosis [52]. Moreover, M. abscessus
isolated from human endophthalmitis cases exhibited in-
creased intracellular survival in endothelial cells and
higher levels of nitric oxide production compared to M.
smegmatis or M. tuberculosis [36]. Thus, the evidence of
higher proliferation of pathogenic mycobacteria in cells
other than macrophages supports our results, in which
CRM0019 shows a more infective profile than the refer-
ence strain in A549 cells.
The success of pathogenic mycobacteria depends on
their ability to survive inside vacuoles and to prevent
phagosome maturation [67–69] and for CRM0019 strain
this may be no different. Our findings show that in both
RAW or BMDM macrophages clinical and reference
strains of M. abscessus were localized in acidified compart-
ments while maintaining proliferative capacity. This is in
contrast to the results obtained with M. smegmatis, in
which the bacilli were, as expected, eliminated in macro-
phages. Regardless of the acidic nature of M. abscessus
phagosomes, no bacterial death was observed up to 72 h
of infection, noted by the constant number of viable col-
onies (CFU). Such behavior is in line with other findings
confirming intracellular survival of M. abscessus in macro-
phages [16, 35, 66, 70]. Indeed, the successful survival of
pathogenic mycobacteria in the potentially hostile envir-
onment of macrophages has been extensively reported for
pathogenic mycobacterium like M. tuberculosis, M. bovis
or M. bovis BCG [39, 69, 71–73]. Such persistent behavior
results in a sustained intracellular survival for several days
[71, 73], being also facilitated by the emergence of
multidrug-resistant strains [74].
Macrophages represent the first line of cellular defense
against pathogens, and it is well known that M. tubercu-
losis is able to subvert the defense machinery of these
cells, which is characterized by production of toxic oxy-
gen and nitrogen radicals, as well as phagosome matur-
ation. Lysosome fusion is the end point to degrade
internalized microbes. Intracellular survival of M. absces-
sus CRM0019 not only in macrophages but also in A549
cells, suggests that this strain has additional strategies to
counteract the intracellular defense machinery. Our
results showed that one difference is the acquisition of
lysosomal proteins by CRM0019, which was not as
significant in RAW as in A549 cells.
Ultrastructural analysis of M. abscessus CRM0019 and
ATCC 19977-containing phagosomes showed that in
RAW macrophages, both bacterial strains reside within
phagosomes, usually consisting of a single bacterium.
Such a characteristic is also supported by recent work
from Roux and collaborators [35]. In their report, the S
variant exhibited a thick GPL-rich cell wall, apposed to
the phagosomal membrane, which is in line with our find-
ings. Nevertheless, in A549 cells, the phagosomal mem-
brane was tightly adherent to the CRM0019 cell wall, a
characteristic usually observed in R variants [16, 35].
Conversely, the ATCC 19977 strain had the phagosomal
membrane loosely associated to its cell wall, a finding that
supports characteristics of S variant, previously described
by other groups [16, 35]. Observations by the de
Chastellier group suggested that pathogenic mycobacteria
have a close apposition of the phagosome membrane, and
that such an arrangement was crucial to prevent phago-
some maturation [75]. CRM0019 also showed a close
membrane apposition to the phagosome in A549 cells,
explaining the prevention in acquisition of lysosomal pro-
teins in the phagosomes. Unexpectedly, these characteris-
tics could not be observed in macrophages.
It has been widely described that S and R variants have
different behavior with regard to their in vivo interactions
as well as with eukaryotic cells. M. abscessus bacteria with
S phenotype avoid immune responses from epithelial cells,
contrasting to bacteria with R phenotype [33]. The S vari-
ant shows indeed an attenuated ability to infect murine
hosts and to persist in human monocytes [16]. From our
results, the infection of CRM0019 in A549 cells had some
peculiar characteristics generally observed for the R mor-
photype, for instance the higher survival. Nonetheless, this
strain showed S morphotype upon isolation. A spontan-
eous transition from S to an R phenotype by M. abscessus
CRM0019 cannot be excluded, since it could contribute to
the establishment of an aggressive and persistent infection.
Some groups have already shown the switch between S to
R variants in CF strains [25, 76].
Reinfection of M. abscessus strains obtained from
macrophages
Following respiratory infection, alveolar macrophages are
essential to eliminate inhaled microbes. Nevertheless,
pathogens can overcome this primary immune defense
and spread the infection, which seems to be the case for
M. abscessus infection. Infected macrophages are also able
to migrate through epithelial and endothelial barriers,
which may contribute to extrapulmonary infections [77].
Within this scenario, we examined the infective compe-
tence of M. abscessus after first infection in macrophages,
in which the bacilli were in a stationary growth phase and
harbored within mature phagosomes (Figs. 2 and 6).
Although second infection occurred to a lesser degree
when compared to initial infection, only the clinical strain
CRM0019 grew in A549 cells and macrophages in a sec-
ond infection, which may explain the long persistence of
the observed in vivo infection [32]. Evidence suggests that
intracellular passage through epithelial cells changes the
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mycobacterial phenotype to a more pathogenic one during
infection of macrophages, epithelial or endothelial cells
[61, 77, 78]. In our study, mycobacteria obtained from
macrophages were not more infective but were still able
to survive in either macrophages or alveolar epithelial
cells. Whether the S morphotype of CRM0019 strain
spontaneously switches to an R morphotype after a first
infection in macrophages is an open question that should
be further investigated. We believe that the release of bac-
teria by macrophages may contribute to subsequent infec-
tions and their persistence in the host. Recently, it was
elegantly shown in a zebrafish model that macrophages
harboring M. abscessus undergo apoptosis and release
bacteria into the extracellular medium, which can be
pathogenic and induce lethal infections [79]. Future work
addressing genomic and transcriptomic changes in M.
abscessus, obtained from a first infection in macrophages
or in alveolar epithelial cells, would help to understand
the adaptation of this bacteria to the intracellular
environment.
Conclusion
In conclusion, this work demonstrated that M. abscessus
CRM0019 survives in alveolar epithelial cells mainly due
to the inhibition of phagosome maturation. Macrophages
containing these bacteria are not able to kill them despite
the mature characteristics of their phagosomes. Finally, M.
abscessus CRM0019 recovered from macrophages are able
to establish a new intracellular infection, which may ex-
plain the aggressive profile of this strain.
Additional files
Additional file 1: Cell viability after M. abscessus infection. (A) A549, (B)
RAW and (C) BMDM were infected for 6-72 h with M. abscessus CRM0019.
Infection did not induce evident cytotoxicity during this time. Data
represent mean ± SD from 2 independent experiments. No statistical
difference was observed for each time point. (TIFF 225 kb)
Additional file 2: Intracellular survival of M. abscessus subsp. abscessus
smooth (MABS), isolated from CF patients. A549 cells infected with M.
abscessus were incubated with or without amikacin, for 6-72 h. Significant
differences between treated and untreated are indicated at each time
point. Data represent mean ± SD from 2 independent experiments.
*p < 0.05, ***p < 0.001. (TIFF 148 kb)
Additional file 3: Growth rate of M. abscessus strains. The CFU obtained
in Fig. 2c was used to calculate the growth rate of M. abscessus CRM0019
or M. abscessus ATCC 19977 in (A) A549, (B) RAW or (C) BMDM cells.
Tf = 24, 48 or 72 h and Ti = 6 h. Data represent mean ± SD from 3
independent experiments. ***p < 0.001; ns: not significant. (TIFF 314 kb)
Additional file 4: M. abscessus CRM0019 phagosome acidification in
A549 cells after 48 h infection. (A) overlay of CRM0019-GFP and Lyso
tracker red; (B) CRM0019; (C) Lyso tracker red. Arrow: intracellular bacteria
loosely associated with acidic vesicles. Bar: 10 μm. (TIFF 14938 kb)
Additional file 5: Colocalization of lysosomal proteins in M. abscessus
ATCC 19977 phagosomes. (A-F) Z-stack images were obtained from RAW
infected for 24 h. (A) Mycobacteria-GFP; (B) LAMP-1: (C) Cathepsin D; (D)
Colocalization of A, B and C; (E) Transmitted light; (F) Colocalization of
GFP, LAMP-1 and DAPI. Bar: 10 μm. (TIFF 27030 kb)
Additional file 6: Growth rate of M. abscessus CRM0019 and M.
abscessus ATCC 19977 after reinfection. (A) A549, (B) RAW or (C) BMDM
cells. Growth rate was determined by the ratio Tf/Ti, in which Tf = 24, 48
or 72 h and Ti = 6 h. ***p < 0.001; ns: not significant. (TIFF 365 kb)
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